Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | RO7444973 |
Trade Name | |
Synonyms | RO-7444973|RO 7444973 |
Drug Descriptions |
RO7444973 is a bispecific T-cell engaging antibody that targets MAGE-A4 and CD3, which potentially leads to activation and targeting of cytotoxic T-lymphocytes to tumor cells expressing MAGE-A4, resulting in tumor cell killing (NCI Drug Dictionary). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | C189056 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
RO7444973 | RO7444973 | 0 | 1 |
RO7444973 + Tocilizumab | RO7444973 Tocilizumab | 0 | 1 |